# Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

> **NCT02843191** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Kyung Hee University Hospital at Gangdong** · enrollment: 358 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT02843191
- **Lead sponsor:** Kyung Hee University Hospital at Gangdong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-12-07
- **Primary completion:** 2023-07-15
- **Final completion:** 2026-06-30
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02843191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02843191, "Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02843191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
